Device Trial Radar · NCT04504890
Ocular-vestibular Biomarker Identification for ADHD
Last checked: Nov 19, 2026Latest source record: Oct 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
240
Planned (sponsor's estimate)
Start
Jul 16, 2020
Primary completion
Aug 5, 2021
Study completion Oct 5, 2021
Sponsor
- Lead sponsor
- Sync-Think, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Sutter Health
- First posted
- Aug 7, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.
Conditions
- ADHD - Combined Type
- ADHD
- ADHD Predominantly Inattentive Type
- ADHD, Predominantly Hyperactive - Impulsive
Interventions
EYE-SYNCDevice
Nystagmograph used to measure eye movement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Eye Tracking and ADHD measure correlationTime frame: through study completion, an average of 1 year
- Eye Tracking ADHD Diagnostic ROCTime frame: through study completion, an average of 1 year
- MANCOVA Eye Tracking in ADHD Treatment PopulationTime frame: through study completion, an average of 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Palo Alto Medical Foundation - San Carlos Center
San Carlos, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.